Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. - Maris,JM.; Weiss,MJ.; Guo,C.; Gerbing,RB.; Stram,DO.; White,PS.; Hogarty,MD.; Sulman,EP.; Thompson,PM.; Lukens,JN.; Matthay,KK.; Seeger,RC.; et al. (J Clin Oncol, 2000)